GSK, Astra, J&J link with universities in new drug research fund: Reuters
GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds ($57 million) fund backing early drug research, Reuters News reported.
25 January 2016•1 min read
